Cases & Deals

Elaia Partners leads €4 million financing round of Mablink Bioscience

Clients Elaia Partners

Jones Day represented Elaia Partners in connection with the €4 million seed round of financing of Mablink Bioscience, a company developing the next generation of antibody-drug conjugates (ADC) through its proprietary hydrophilic drug-linker PSARlink™ platform.